Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for ...

I maintain a Neutral view on CSL Limited due to the mixed prospects for its flu vaccine (Seqirus) and plasma therapy (Behring ...

Farther Finance Advisors LLC boosted its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 123.6% during the fourth quarter, Holdings Channel reports. The institutional ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Harmony Biosciences (HRMY) announced the appointment of Adam Zaeske as executive VP and chief commercial officer, effective March 31. The ...

M&T Bank Corp lowered its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 10.0% in the 4th ...

In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited (NYSE:TAK) stands against the other pharma stocks. Healthcare, which includes numerous businesses that offer ...

This is the latest sign of global healthcare giants doubling down on the market in recent years. Experts noted on Monday that ...

China's unwavering commitment to opening-up will propel new industrialization, green growth and digital transformation, showcasing the nation's growing strength in innovation and demand-driven ...

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...